Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.
Lancet
; 369(9561): 559-70, 2007 Feb 17.
Article
in En
| MEDLINE
| ID: mdl-17307102
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tamoxifen
/
Breast Neoplasms
/
Selective Estrogen Receptor Modulators
/
Aromatase Inhibitors
/
Androstadienes
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Lancet
Year:
2007
Document type:
Article
Affiliation country:
Reino Unido
Country of publication:
Reino Unido